Phocas Financial Corp’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-72,371
Closed -$8.34M 220
2018
Q2
$8.34M Sell
72,371
-670
-0.9% -$73.3K 0.72% 63
2018
Q1
$6.27M Sell
73,041
-49,695
-40% -$3.85M 0.57% 75
2017
Q4
$9.09M Sell
122,736
-5,207
-4% -$348K 0.76% 62
2017
Q3
$7K Buy
127,943
+2,853
+2% +$169K 0.59% 72
2017
Q2
$8.02M Buy
125,090
+5,575
+5% +$344K 0.72% 58
2017
Q1
$6.88M Sell
119,515
-16,291
-12% -$972K 0.64% 65
2016
Q4
$8.31M Buy
135,806
+57,468
+73% +$3.74M 0.55% 70
2016
Q3
$5.42M Buy
+78,338
New +$5.17M 0.38% 119
2014
Q2
Sell
-116,186
Closed -$4.38M 230
2014
Q1
$4.38M Sell
116,186
-9,074
-7% -$317K 0.42% 117
2013
Q4
$4.73M Sell
125,260
-1,420
-1% -$54.3K 0.44% 116
2013
Q3
$5.5M Buy
126,680
+740
+0.6% +$29.7K 0.53% 78
2013
Q2
$4.56M Buy
+125,940
New +$3.83M 0.48% 89

Other funds holding USNA

Phocas Financial Corp's USNA Position: Q3 2018 in Review

Phocas Financial Corp sold out of Usana Health Sciences (USNA) in Q3 2018, closing a stake of 72,371 shares — an estimated $8.34M sold.

Phocas Financial Corp first reported a position in USNA in Q2 2013 and held it in 12 quarters. The position peaked at $9.09M in Q4 2017. 197 funds tracked by Wall St. Rank hold USNA as of Q3 2018.

  • Phocas Financial Corp reported no remaining Usana Health Sciences position as of Q3 2018 after selling out during the quarter.
  • Phocas Financial Corp sold 72,371 Usana Health Sciences shares in Q3 2018, an estimated $8.34M.
  • Phocas Financial Corp first reported a position in Usana Health Sciences in Q2 2013 and held it in 12 quarters.
  • Phocas Financial Corp's Usana Health Sciences position peaked at $9.09M in Q4 2017.
  • 197 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2018.

Based on Phocas Financial Corp's 13F filing for Q3 2018, filed 15 Nov 2018.